Streetbeat News

Analyst Ratings

BYD

Over the past 3 months, 5 analysts have published their opinion on Boyd Gaming (NYSE:BYD) stock. The average 12-month price target for Boyd Gaming is $78.4, with a high of $85.00 and a low of $69.00. This average price target has increased by 6.67% over the past month.

Portfolio Pulse from Benzinga Insights

July 31, 2023 | 7:03 pm

CRWD

In the last quarter, CrowdStrike Holdings (NASDAQ:CRWD) received 28 bullish and 1 indifferent ratings from 29 analysts. The company's average 12-month price target is $180.69, an increase of 8.85% from the previous average of $166.00. The high and low price targets are $235.00 and $128.00 respectively.

Portfolio Pulse from Benzinga Insights

July 31, 2023 | 7:02 pm

CFR

Over the last quarter, Cullen/Frost Bankers (NYSE:CFR) received 8 analyst ratings, with 1 being bullish, 1 somewhat bullish, and 6 indifferent. The company's average 12-month price target is $120.25, a decrease of 3.22% from the previous average of $124.25.

Portfolio Pulse from Benzinga Insights

July 31, 2023 | 7:01 pm

EXP

Truist Securities analyst Keith Hughes has reiterated a Buy rating on Eagle Materials Inc (EXP), raising the price target to $220 from $195. The company's Q1 2024 revenues rose 7% Y/Y to $601.5 million, with strong cement pricing and slower-than-expected wallboard results. Hughes expects the bottom of the wallboard market in the next two to three quarters, but no substantial contraction in earnings is anticipated. The company's plants are near sold-out conditions due to heavy demand, and double-digit pricing increases have been announced in about half their cement markets.

Portfolio Pulse from Nabaparna Bhattacharya

July 31, 2023 | 7:00 pm

MGPI

Truist Securities analyst Bill Chappell reiterated a Buy rating on MGP Ingredients, Inc. (MGPI) with a price target of $125. The analyst believes the company's recent acquisitions, including high-end whiskey brand Penelope, and the exit from third party manufacturing of vodka, gin and industrial alcohol will boost the company's valuation. The analyst expects MGPI's valuation to move closer to the 20-25X forward EBITDA valuation of its large cap spirits peers versus the current 14.2x EV/EBITDA valuation.

Portfolio Pulse from Shivani Kumaresan

July 31, 2023 | 6:58 pm

ACAX

ACHR

GDRX

SILC

UFAB

YELL

U.S. stocks were mixed with the Dow Jones and NASDAQ slightly up and the S&P 500 slightly down. Energy shares climbed by 2% while health care shares fell by 0.9%. Yellow Corporation shares shot up 91% after terminating its operations. GoodRx Holdings shares rose 38% after an upgrade from TD Cowen. Archer Aviation shares gained 43% after entering into contracts with the US Air Force. Unique Fabricating, Alset Capital Acquisition Corp., and Silicom Ltd. shares dropped after various events.

Portfolio Pulse from Lisa Levin

July 31, 2023 | 6:54 pm

CNHI

Oppenheimer analyst Kristen Owen reiterated an Outperform rating on CNI Industrial NV (NYSE:CNHI) but lowered the price target from $19 to $18. CNI reported Q2 revenue of $6.57 billion, beating the consensus estimate of $6.44 billion. The company reaffirmed FY23 guidance, including IA net sales growth of 8-11%. The analyst noted solid operating results, proactive inventory management, and potential for improved value capture from key megatrends.

Portfolio Pulse from Shivani Kumaresan

July 31, 2023 | 6:54 pm

AMAM

RBC Capital Markets has initiated coverage on Ambrx Biopharma Inc (NASDAQ:AMAM) with an Outperform rating and a price target of $29. The analysts see potential for significant growth due to the company's promising prostate cancer program and an undervalued asset in Her2+ breast cancer. They believe the company's unique ADC constructs may provide therapeutic advantages over other products. If clear evidence of post-Enhertu activity emerges from the expected trial of ARX788 updates over the next 18 months, it could reignite enthusiasm for a substantial annual U.S. sales opportunity of approximately $400 million.

Portfolio Pulse from Vandana Singh

July 31, 2023 | 6:50 pm

SHOP

A significant amount of unusual options activity has been detected for Shopify (NYSE:SHOP), with 68% of investors opening trades with bullish expectations and 31% with bearish. Whales have been targeting a price range from $12.5 to $90.0 for Shopify over the last 3 months. The price of SHOP is currently up 1.82% at $67.24. Analysts from Evercore ISI Group and Morgan Stanley have downgraded their ratings to In-Line and Equal-Weight respectively, while Credit Suisse and Roth MKM have maintained their Neutral and Buy ratings.

Portfolio Pulse from Benzinga Insights

July 31, 2023 | 6:46 pm

PNC

A significant amount of unusual options activity has been observed for PNC Financial Services Group (NYSE:PNC), with a predominantly bearish sentiment. Whales have been targeting a price range from $115.0 to $150.0 for PNC over the last 3 months. The current price of PNC is $135.6, up 0.07%. Morgan Stanley maintains an Underweight rating on PNC with a price target of $144, while Credit Suisse maintains a Neutral rating with a price target of $135.

Portfolio Pulse from Benzinga Insights

July 31, 2023 | 6:46 pm